Pro-Dex Inc (NASDAQ:PDEX) Director William James Farrell III bought 2,200 shares of the stock in a transaction dated Monday, February 12th. The stock was bought at an average price of $6.75 per share, with a total value of $14,850.00. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.
Pro-Dex Inc (NASDAQ:PDEX) traded up $0.15 during mid-day trading on Tuesday, hitting $6.95. The stock had a trading volume of 15,200 shares, compared to its average volume of 9,893. Pro-Dex Inc has a fifty-two week low of $4.30 and a fifty-two week high of $8.00.
A hedge fund recently raised its stake in Pro-Dex stock. Acadian Asset Management LLC increased its stake in Pro-Dex Inc (NASDAQ:PDEX) by 372.5% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 16,316 shares of the medical instruments supplier’s stock after buying an additional 12,863 shares during the quarter. Acadian Asset Management LLC owned about 0.37% of Pro-Dex worth $111,000 as of its most recent filing with the SEC. Institutional investors own 3.92% of the company’s stock.
ILLEGAL ACTIVITY WARNING: This news story was originally published by American Banking News and is owned by of American Banking News. If you are accessing this news story on another website, it was copied illegally and republished in violation of US and international copyright and trademark legislation. The correct version of this news story can be viewed at https://www.americanbankingnews.com/2018/02/13/pro-dex-inc-pdex-director-buys-14850-00-in-stock.html.
Pro-Dex, Inc (Pro-Dex) designs and produces surgical and dental instruments and motion control products used in the medical, factory automation and scientific research industries. The Company operates through four segments: Pro-Dex, OMS, Fineline and Engineering Services Division (ESD). The Pro-Dex segment provides primarily medical and dental instruments using shared production and assembly machines and workforce.
Receive News & Ratings for Pro-Dex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro-Dex and related companies with MarketBeat.com's FREE daily email newsletter.